Items
Displaying 1046151-1046200 of 1306131 results.
| Cat.No. | Description | Unit Of Measure |
|---|---|---|
| 45-CBR01582-1G-EA | Discontinued | EA |
| 45-CBR00826-1G-EA | 3-(2-Aminoethyl)-1, 3-oxazinan-2-one | EA |
| 45-JRD0396-1G-EA | 6-Bromo-2, 2-dimethyl-2H-benzo[b][1, | EA |
| 45-OTV000761-1G-EA | 4-Methyl-3, 4-dihydro-2H-benzo[b][1, | EA |
| 45-BML00289-1G-EA | 5-(Methylsulfonyl)pyridine-3-boronic | EA |
| 45-MSQC13-100UG-EA | SILu(TM)MAb Rituximab Stable-Isotope | EA |
| 45-07566-5MG-EA | Discontinued | EA |
| 45-05991501-1ML-EA | Discontinued | EA |
| 45-H17001-5UG-EA | Wnt3A, human, recombinant, expressed | EA |
| 45-Z203092-1EA-EA | Discontinued | EA |
| 45-900710-10ML-EA | Boron nitride, nanoplatelet, 0.1-0.5 | EA |
| 45-18597-500ML-EA | Triethylammonium bicarbonate buffer, | EA |
| 45-901330-100MG-EA | Bis-MPA-NHBoc dendrimer, trimethylol | EA |
| 45-BBO000677-1G-EA | cis-6-Amino-cyclohex-3-enecarboxylic | EA |
| 45-CBR01583-1G-EA | 4, 4-Dimethyl-1, 3-oxazolidin-2-one, | EA |
| 45-BLN00004-1G-EA | 3-Bromo-1H-pyrazolo[3, 4-c]pyridine, | EA |
| 45-CBR02085-1G-EA | Discontinued | EA |
| 45-BBO000304-1G-EA | 4-Amino-6-trifluoromethoxyquinoline, | EA |
| 45-CBR01645-1G-EA | 1-Methyl-4-piperidinecarbohydrazide, | EA |
| 45-CBR02448-1G-EA | 2-(2-Furyl)ethanamine hydrochloride, | EA |
| 45-CDS009645-100MG-EA | Discontinued | EA |
| 45-CDS017041-50MG-EA | Discontinued | EA |
| 45-VBP00291-1G-EA | (R)-5-(oxiran-2-ylmethoxy)quinoline, | EA |
| 45-EME00347-1G-EA | N-Methyl-1, 2-benzisothiazol-3-amine | EA |
| 45-BBO000448-1G-EA | 4-(3, 4-Dimethoxy-benzyl)-piperidine | EA |
| 45-BBO000485-1G-EA | 2-(3, 4-Dimethoxy-benzyl)-piperidine | EA |
| 45-CBR02445-1G-EA | 8-Hydrazinoquinoline dihydrochloride | EA |
| 45-CBR01621-1G-EA | Discontinued | EA |
| 45-CBR00889-1G-EA | Discontinued | EA |
| 45-CBR02027-1G-EA | Discontinued | EA |
| 45-CBR02345-1G-EA | [3-(Aminomethyl)benzyl]dimethylamine | EA |
| 45-BOG00255-1G-EA | 2-(2-Amino-3-pyridyl)benz-imidazole, | EA |
| 45-41344-50MG-EA | 1-Hydroxypyrene, certified reference | EA |
| 45-SAB4200768-1VL-EA | Anti-Human IgG1-Peroxidase antibody, | EA |
| 45-SAB4200769-1VL-EA | Anti-Human IgG3-Peroxidase antibody, | EA |
| 45-SAB4200770-1VL-EA | Anti-Human IgG4-Peroxidase antibody, | EA |
| 45-PH015912-100MG-EA | Methyl 5, 5-dimethyl-3-oxohexanoate, | EA |
| 45-PH015900-100MG-EA | Ethyl 5-benzyloxazole-4-carboxylate, | EA |
| 45-PH015995-1G-EA | 2-(2-tert-Butoxypropoxy)-1-propanol, | EA |
| 45-PH016043-250MG-EA | 1-(2-Propynyl)cyclopentyl carbamate, | EA |
| 45-PH016079-500MG-EA | 2-Bromo-3-isobutylcyclopent-2-enone, | EA |
| 45-PH016008-250MG-EA | 3, 4-Dihydro-1-naphthalenecarboxylic | EA |
| 45-PH016029-250MG-EA | 4-(3-(Piperazin-1-yl)propoxy)benzoic | EA |
| 45-PH015914-100MG-EA | 2-(3-Hydroxypropoxy)-1H-isoindole-1, | EA |
| 45-PH015984-1G-EA | Methyl isothiazolidine-3-carboxylate | EA |
| 45-PH015928-100MG-EA | 1, 2, 7, 7a-Tetrahydro-3H-pyrrolo[1, | EA |
| 45-PH016052-250MG-EA | 1-Benzyl 4-tert-butyl 6-methylene-1, | EA |
| 45-900185-100ML-EA | Monodispersed nanodiamond particles, | EA |
| 45-900178-100ML-EA | Monodispersed nanodiamond particles, | EA |
| 45-900177-100ML-EA | Monodispersed nanodiamond particles, | EA |
